Conference Details - Faculty

View all Conferences

Continuing Education Information

Physicians: Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity is approved for AMA PRA Category 1 Credit™

Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.

Sixth Annual Symposium on Controversies and Clinical Challenges In Lymphoma, Myeloma, and Leukemia

Pointe Hilton Tapatio Cliffs
Phoenix, AZ
September 11-12, 2009

Program Director

Sundar Jagannath, MD
Professor of Medicine
New York Medical College
Chief, Multiple Myeloma and Transplant Program
St. Vincent’s Comprehensive Cancer Center
New York, NY

Faculty

P. Leif Bergsagel, MD, FRCP(C)
Consultant
Mayo Clinic Arizona
Scottsdale, AZ

Harry Erba, MD, PhD
Associate Professor of Internal Medicine
University of Michigan Health System
Ann Arbor, MI

Stefan Faderl, MD
Associate Professor of Medicine
Department of Leukemia
Division of Cancer Medicine
The University of Texas M. D. Anderson Cancer Center
Houston, TX

Michelle Fanale, MD
Assistant Professor of Medicine
Department of Lymphoma and Myeloma
The University of Texas M. D. Anderson Cancer Center
Houston, TX

Rafael Fonseca, MD
Consultant, Professor of Medicine
Deputy Director
Mayo Clinic Cancer Center
Scottsdale, AZ

André Goy, MD
Deputy Director, The Cancer Center
Chief, Division of Lymphoma
Director, The Tumor Bank
The Cancer Center at Hackensack University Medical Center
Hackensack, NJ

Jeffrey Jones, MD, MPH
Assistant Professor
Division of Hematology/Oncology
The Ohio State University Comprehensive Cancer Center
Columbus, OH

Shaji Kumar, MD
Associate Professor
Mayo Clinic
Rochester, MN

Nicole Lamanna, MD
Assistant Attending Physician
Leukemia Service
Memorial Sloan-Kettering Cancer Center
New York, NY

Ola Landgren, MD, PhD
Principal Investigator
Medical Oncology Branch
National Cancer Institute
National Institutes of Health
Bethesda, MD

Ruben A. Mesa, MD
Professor of Medicine
Consultant, Hematology and Oncology
Mayo Clinic
Scottsdale, AZ

Thomas P. Miller, MD
Professor of Medicine
Chief, Section of Hematology/Oncology
Arizona Cancer Center
University of Arizona
Phoenix, AZ

Barbara Pro, MD
Associate Professor of Medicine
The University of Texas M. D. Anderson Cancer Center
Houston, TX

Farhad Ravandi, MD
Associate Professor of Medicine
Department of Leukemia
The University of Texas M. D. Anderson Cancer Center 
Houston, TX

Edward Stadtmauer, MD
Professor of Medicine
Director, Bone Marrow and Stem Cell Transplant Program
Director, Hematologic Malignancies Program
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, PA

Keith Stewart, MD
Professor of Medicine
Consultant
Division of Hematology/Oncology
College of Medicine, Mayo Clinic
Scottsdale, AZ

John Sweetenham, MD
Professor of Medicine
Director, Clinical Research
Cleveland Clinic Taussig Cancer Institute
Cleveland, OH

Raoul Tibes, MD, PhD
Director, Hematological Malignancies Program
Assistant Clinical Investigator
Genomics Medicine and Individualized Therapy Center
TGen Clinical Research Services at Scottsdale Healthcare (TCRS)
Associate Investigator
Translational Genomics Research Institute (TGen)
Scottsdale, AZ

Parameswaran Venugopal, MD
The Samuel G. Taylor, III, MD Chair in Oncology
Professor of Medicine
Co-Director, Section of Hematology
Rush University Medical Center
Chicago, IL

Wyndham H. Wilson, MD, PhD
Senior Investigator and Chief, Lymphoma Therapeutics
Metabolism Branch
Chief, Lymphoma Clinic
Medicine Branch
Center for Cancer Research
National Cancer Institute, National Institutes of Health
Bethesda, MD

Maurizio Zangari, MD
Professor of Medicine
The University of Utah School of Medicine
Salt Lake City, UT

Educational Grants

An educational grant for this activity was provided by:


  1. Cephalon Oncology
  2. Merck Oncology
  3. Millennium Pharmaceuticals, Inc.
  5. Novartis Oncology
  7. Celgene Corporation